Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Detalo Health ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   0.0% 8.2% 7.1% 6.9% 7.2% 3.7% 18.0% 17.7%   Credit score (0-100)   0 31 34 33 33 51 8 9   Credit rating   N/A BB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 1,477 547 1,292 2,132 2,771 2,771 2,771   Gross profit   0.0 417 289 -249 1,029 679 0.0 0.0   EBITDA   0.0 417 -16.2 -249 1,029 598 0.0 0.0   EBIT   0.0 417 -16.2 -249 1,029 598 0.0 0.0   Pre-tax profit (PTP)   0.0 407.6 -26.1 -267.8 1,027.3 590.6 0.0 0.0   Net earnings   0.0 317.9 -20.9 -211.8 800.1 458.3 0.0 0.0   Pre-tax profit without non-rec. items   0.0 408 -26.1 -268 1,027 591 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 368 347 135 935 794 544 544   Interest-bearing liabilities   0.0 600 0.0 0.0 93.2 249 0.0 0.0   Balance sheet total (assets)   0.0 1,894 680 782 1,266 1,290 544 544   Net Debt   0.0 -121 -320 -253 -463 -118 -544 -544     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 1,477 547 1,292 2,132 2,771 2,771 2,771   Net sales growth   0.0% 0.0% -63.0% 136.3% 65.1% 30.0% 0.0% 0.0%   Gross profit   0.0 417 289 -249 1,029 679 0.0 0.0   Gross profit growth   0.0% 0.0% -30.8% 0.0% 0.0% -34.0% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 1,894 680 782 1,266 1,290 544 544   Balance sheet change%   0.0% 0.0% -64.1% 15.1% 61.8% 1.9% -57.9% 0.0%   Added value   0.0 417.0 -16.2 -248.9 1,029.1 598.0 0.0 0.0   Added value %   0.0% 28.2% -3.0% -19.3% 48.3% 21.6% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 -1.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   0.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 28.2% -3.0% -19.3% 48.3% 21.6% 0.0% 0.0%   EBIT %   0.0% 28.2% -3.0% -19.3% 48.3% 21.6% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 100.0% -5.6% 100.0% 100.0% 88.1% 0.0% 0.0%   Net Earnings %   0.0% 21.5% -3.8% -16.4% 37.5% 16.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 21.5% -3.8% -16.4% 37.5% 16.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 27.6% -4.8% -20.7% 48.2% 21.3% 0.0% 0.0%   ROA %   0.0% 22.0% -1.2% -34.0% 100.5% 47.1% 0.0% 0.0%   ROI %   0.0% 43.1% -2.3% -103.2% 176.9% 58.1% 0.0% 0.0%   ROE %   0.0% 86.4% -5.8% -87.8% 149.5% 53.0% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 19.4% 51.1% 17.3% 73.9% 61.5% 100.0% 100.0%   Relative indebtedness %   0.0% 103.3% 60.9% 50.1% 15.5% 17.9% 0.0% 0.0%   Relative net indebtedness %   0.0% 54.5% 2.3% 30.5% -10.6% 4.7% -19.6% -19.6%   Net int. bear. debt to EBITDA, %   0.0% -29.0% 1,975.3% 101.7% -45.0% -19.7% 0.0% 0.0%   Gearing %   0.0% 163.1% 0.0% 0.0% 10.0% 31.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 3.1% 3.7% 0.0% 3.9% 6.2% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 1.2 1.5 1.0 3.0 1.7 0.0 0.0   Current Ratio   0.0 1.2 2.0 1.2 3.8 2.6 0.0 0.0   Cash and cash equivalent   0.0 720.8 320.3 253.2 555.9 366.7 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 182.0 8.9 84.1 71.2 54.8 0.0 0.0   Trade creditors turnover (days)   0.0 229.1 0.0 1.8 86.3 83.2 0.0 0.0   Current assets / Net sales %   0.0% 128.2% 124.4% 60.6% 59.4% 46.5% 19.6% 19.6%   Net working capital   0.0 367.9 347.1 135.3 935.3 793.6 0.0 0.0   Net working capital %   0.0% 24.9% 63.5% 10.5% 43.9% 28.6% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 2,771 0 0   Added value / employee   0 0 0 0 0 598 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 598 0 0   EBIT / employee   0 0 0 0 0 598 0 0   Net earnings / employee   0 0 0 0 0 458 0 0